Business
Result of GM and total voting rights
Result of GM and total voting rights.
About this update from Fusion Antibodies Plc
[{"type":"text","content":"\n\n8 June 2023\n \nFusion Antibodies plc\n(\"Fusion\" or the \"Company\")\n \nResult of General Meeting\nand\nTotal Voting Rights\n \nFusion Antibodies plc (AIM: FAB), specialists in pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications, announces that at the general meeting of the Company, held earlier today, all resolutions were duly passed.\n \nFollowing the passing of the resolutions, the Company has raised a total of £1,671,938.40 pursuant to the Fundraise, details of which were announced on 19 May 2023 and 23 May 2023. Application has been made for the admission of the 25,830,252 Second Tranche Placing Shares, the 2,740,000 Subscription Shares and the 2,267,022 Retail Offer Shares to trading on AIM (\"Second Admission\") and Second Admission is expected to occur on 12 June 2023.\n \nDirectors' holdings\n \nDetails of the interests of the Directors who participated in the Fundraise and their resultant holdings of Ordinary Shares following Second Admission are as follows:\n \n\n\n\nDirector/PDMR/PCA\n\n\nExisting beneficial shareholding\n\n\nSubscription Shares subscribed for\n\n\nBeneficial shareholding on Second Admission\n\n\nPercentage of enlarged issued share capital\n\n\n\n\nSimon Douglas\n\n\n255,800\n\n\n200,0001\n\n\n455,800\n\n\n0.77%\n\n\n\n\nAdrian Kinkaid\n\n\n4,000\n\n\n140,000\n\n\n144,000\n\n\n0.24%\n\n\n\n\nSonya Ferguson\n\n\n102,567\n\n\n400,000\n\n\n502,567\n\n\n0.85%\n\n\n\n\nColin Walsh2\n\n\n-\n\n\n600,0003\n\n\n600,000\n\n\n1.01%\n\n\n\n\nHamniv (GP) Limited4\n\n\n-\n\n\n1,400,000\n\n\n1,400,000\n\n\n2.35%\n\n\n\n \n1 Subscription Shares applied for by relatives of Simon Douglas\n2 Colin Walsh is the Chief Executive and founder of Crescent Capital NI Limited (\"Crescent Capital\"), which is the fund manager for Crescent Capital III LP which holds 613,382 Ordinary Shares.\n3 Subscription shares applied for by Walsh Strategic Management Limited, a company controlled by Colin Walsh\n4 Hamniv (GP) Limited is a subsidiary of Crescent Capital.\n \nTotal voting rights\n \nFollowing Second Admission, the number of Ordinary Shares in issue and number of voting rights will be 59,453,714. The above figure may be used by shareholders as the denominator for the calculations by which they will...